Custom Peptide Libraries
Genscript Corporation SARS-CoV-2 Spike protein RBD
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19) the respiratory illness responsible for the COVID-19 pandemic SARS-CoV-2 also known as 2019-nCoV is a positive-sense single-stranded RNA virus and is believed to have zoonotic origins and has close genetic similarity to bat coronaviruses The receptor binding domain (RBD) of spike protein of the SARS-CoV-2 virus binds Angiotensin-Converting Enzyme 2 (ACE2) to invade the host cells Based on structural biology studies the RBD can be oriented either in the up/standing or down/lying state with the up/standing state associated with higher pathogenicity
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases As of May 2021 three sublineages have been found Despite its name B 1 617 3 was the first sublineage of this variant to be detected in October 2020 in India This sublineage has remained relatively uncommon compared to the two other sublineages B 1 617 1 (also known as variant Kappa) and B 1 617 2 (also known as variant Delta) both of which were first detected in December 2020 This variant has the double mutations E484Q and L452R in the spike proteins Emerging research suggests the variant may be more transmissible than previously evolved ones Whether the effectiveness of currently-deployed vaccines is affected remains under investigation Moreover the sublineage B 1 617 2 has been redesignated as variant of concern (VOC-21APR-02) in May 2021 which spreads more quickly than the origin
Cell Signaling Technology SARS-CoV-2 Spike Protein F3Q9R Rabbit mAb 100 ul
SARS-CoV-2 Spike Protein F3Q9R Rabbit mAb 100 ul
Abcam DADLE, delta-Opioid peptide agonist, 1MG
MW 569.66 g/mol, Purity >95%. Synthetic δ-opioid peptide agonist, with some activity at μ-opioid receptors. Neuro- and tissue-protective properties. Attenuates mRNA expression of p53 and c-fos.
The product is subject to the following: Abcam Restricted Use Statement
Bioss Prostate Secretory Protein/PSP
Prostate Secretory Protein/PSP Primary Antibody Unconjugated Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB IHC-P IHC-F IP IF RecombinantConcentration 1ug/ul Size 100 ul Storage Buffer 10mM phosphate buffered saline(pH 7 4) with 150mM sodium chloride 0 05% BSA 0 02% sodium azide and 50% glycerol
ABclonal Technology Actin (plant specific) Rabbit pAb
Actins are highly conserved proteins that are involved in cell motility, structure, and integrity. This actin is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins.
![Biolegend TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502551028.png-250.jpg)
Biolegend TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug
TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases As of May 2021 three sublineages have been found Despite its name B 1 617 3 was the first sublineage of this variant to be detected in October 2020 in India This sublineage has remained relatively uncommon compared to the two other sublineages B 1 617 1 (also known as variant Kappa) and B 1 617 2 (also known as variant Delta) both of which were first detected in December 2020 This variant has the double mutations E484Q and L452R in the spike proteins Emerging research suggests the variant may be more transmissible than previously evolved ones Whether the effectiveness of currently-deployed vaccines is affected remains under investigation Moreover the sublineage B 1 617 2 has been redesignated as variant of concern (VOC-21APR-02) in May 2021 which spreads more quickly than the origin
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases As of May 2021 three sublineages have been found Despite its name B 1 617 3 was the first sublineage of this variant to be detected in October 2020 in India This sublineage has remained relatively uncommon compared to the two other sublineages B 1 617 1 (also known as variant Kappa) and B 1 617 2 (also known as variant Delta) both of which were first detected in December 2020 This variant has the double mutations E484Q and L452R in the spike proteins Emerging research suggests the variant may be more transmissible than previously evolved ones Whether the effectiveness of currently-deployed vaccines is affected remains under investigation Moreover the sublineage B 1 617 2 has been redesignated as variant of concern (VOC-21APR-02) in May 2021 which spreads more quickly than the origin
Cayman Chemical MRSCoV SpIke GlycoproteIn R
Immunogen: Recombinant MERS-CoV spike glycoprotein • Host: Rabbit • Species Reactivity: (+) MERS-CoV • Cross Reactivity: (+) MERS-CoV spike glycoprotein, MERS-CoV spike glycoprotein S1, MERS-CoV spike glycoprotein RBD; (-) MERS-CoV spike glycoprotein S2 • Application: MN
Cayman Chemical MRSCoV SpIke GlycoproteIn R
Immunogen: Recombinant MERS-CoV spike glycoprotein • Host: Rabbit • Species Reactivity: (+) MERS-CoV • Cross Reactivity: (+) MERS-CoV spike glycoprotein, MERS-CoV spike glycoprotein S1, MERS-CoV spike glycoprotein RBD; (-) MERS-CoV spike glycoprotein S2 • Application: MN
Cayman Chemical AcMNPV Major Envelope Glycopr
Immunogen: Recombinant AcMNPV (strain E2) • Host: Mouse • Species Reactivity: (+) AcMNPV • Cross Reactivity: (+) Major envelope glycoprotein • Applications: MN
Genscript Corporation HEK293T/Spike Stable Cell Line
Recombinant HEK293T cells stably overexpress coronavirus SARS-CoV-2 spike protein on the surface The surface expression of SARS-CoV-2 spike protein is validated by FACS analysis This stable cell line product is designed for screening antibodies against SARS-CoV-2 spike protein as well as for measuring binding affinity and stability of antibody based biologics that bind with spike protein GenScript also offers spike protein expressing CHO-K1 stable cell line (Cat No M00803) for SARS-CoV-2 study